21 May 2009
Results of simultaneous kidney and pancreas transplantation – an evaluative study
J Szmidt, T Grochowiecki, K Grygiel, Z Gałązka, S Nazarewski, K Madej, M Durlik, S Frunze, H Feiz, L PączekAnn Transplant 2009; 14(1): 23-23 :: ID: 880280
Abstract
The purpose of our study was to evaluate the results of simultaneous kidney and pancreas transplantation. Between Feb. 1988 and Jan. 2009, 101transplantations were performed. Type 1 diabetes, complicated by end-stage renal insufficiency was an indication. 25 segmental pancreas transplantations were accomplished. In 76 patients total pancreas transplantation was performed including 12 cases with venous anastomosis to the portal system. Patient's follow-up ranged from 1 to 242 months. Cumulative patient's survival rates in 1, 3, 5, 10, 12 years post transplantation were 78%, 73%, 67%, 50%, 43% respectively. Cumulative graft survival rates in 1, 3, 5, 10, 12 years post transplantation were for kidney grafts: 90%, 85%, 76%, 68%, and 68% and for pancreas transplants: 67%, 62%, 59%, 51%, and 51% respectively. Excluding from analysis 6 primarily non-functioning pancreatic segment transplantations no differences in functioning of the transplanted whole and segmental pancreatic grafts were observed. Infections were the main cause of death in the first 18 months after transplantation (20/22; 91%). Deaths in the later period were caused by cardiovascular complications (11/13; 84.6%) (p<0.01). Cumulated survival rates of long term functioning technically successful simultaneous pancreas and kidney transplants were similar and did not present any statistically significant differences. Sepsis was the main cause of deaths within the first 18 months after pancreas transplantation.
Keywords: Kidney Transplantation, Pancreas Transplantation
In Press
Original article
Diagnostic Utility of FAR1 Methylation Levels in Hepatocellular Carcinoma Patients Undergoing Liver Transpl...Ann Transplant In Press; DOI: 10.12659/AOT.951568
Original article
Inferior Long-Term Outcome of Fatty Liver Allografts After Orthotopic Liver TransplantationAnn Transplant In Press; DOI: 10.12659/AOT.950589
Database Analysis
Identification and Validation of Liver Transplantation-Induced Acute Lung Injury Biomarkers Using a Bioinfo...Ann Transplant In Press; DOI: 10.12659/AOT.950289
Original article
Survival and Recurrence in Liver Transplant Patients With Intrahepatic Cholangiocarcinoma and Hepatocellula...Ann Transplant In Press; DOI: 10.12659/AOT.950997
Most Viewed Current Articles
24 Aug 2021 : Review article 18,372
Normothermic Machine Perfusion (NMP) of the Liver – Current Status and Future PerspectivesDOI :10.12659/AOT.931664
Ann Transplant 2021; 26:e931664
05 Apr 2022 : Original article 14,731
Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver TransplantationDOI :10.12659/AOT.935604
Ann Transplant 2022; 27:e935604
22 Nov 2022 : Original article 14,244
Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...DOI :10.12659/AOT.937988
Ann Transplant 2022; 27:e937988
29 Dec 2021 : Original article 13,752
Efficacy and Safety of Tacrolimus-Based Maintenance Regimens in De Novo Kidney Transplant Recipients: A Sys...DOI :10.12659/AOT.933588
Ann Transplant 2021; 26:e933588






